» Articles » PMID: 36439687

The Role of Oxidative Stress in Acute Ischemic Stroke-Related Thrombosis

Overview
Publisher Wiley
Date 2022 Nov 28
PMID 36439687
Authors
Affiliations
Soon will be listed here.
Abstract

Acute ischemic stroke is a serious life-threatening disease that affects almost 600 million people each year throughout the world with a mortality of more than 10%, while two-thirds of survivors remain disabled. However, the available treatments for ischemic stroke are still limited to thrombolysis and/or mechanical thrombectomy, and there is an urgent need for developing new therapeutic target. Recently, intravascular oxidative stress, derived from endothelial cells, platelets, and leukocytes, has been found to be tightly associated with stroke-related thrombosis. It not only promotes primary thrombus formation by damaging endothelial cells and platelets but also affects thrombus maturation and stability by modifying fibrin components. Thus, oxidative stress is expected to be a novel target for the prevention and treatment of ischemic stroke. In this review, we first discuss the mechanisms by which oxidative stress promotes stroke-related thrombosis, then summarize the oxidative stress biomarkers of stroke-related thrombosis, and finally put forward an antithrombotic therapy targeting oxidative stress in ischemic stroke.

Citing Articles

Galangin's Neuroprotective Role: Targeting Oxidative Stress, Inflammation, and Apoptosis in Ischemic Stroke in a Rat Model of Permanent Middle Cerebral Artery Occlusion.

Palachai N, Supawat A, Kongsui R, Klimaschewski L, Jittiwat J Int J Mol Sci. 2025; 26(5).

PMID: 40076473 PMC: 11899015. DOI: 10.3390/ijms26051847.


Advances in the detection of biomarkers for ischemic stroke.

Liang Y, Chen J, Chen Y, Tong Y, Li L, Xu Y Front Neurol. 2025; 16:1488726.

PMID: 40066310 PMC: 11891058. DOI: 10.3389/fneur.2025.1488726.


Reactive Oxygen Species, a Potential Therapeutic Target for Vascular Dementia.

White A, Talkington G, Ouvrier B, Ismael S, Solch-Ottaiano R, Bix G Biomolecules. 2025; 15(1).

PMID: 39858401 PMC: 11761268. DOI: 10.3390/biom15010006.


Neuroprotective Efficacy of in Ischemic Stroke: Antioxidant and Anti-Inflammatory Mechanisms.

Hong Y, Ko G, Jeon Y, Baek H, Lee J, Lee D Cells. 2025; 14(2.

PMID: 39851546 PMC: 11764225. DOI: 10.3390/cells14020117.


Transcriptome Sequencing-Based Screening of Key Melatonin-Related Genes in Ischemic Stroke.

Li T, Li H, Zhang S, Wang Y, He J, Kang J Int J Mol Sci. 2024; 25(21).

PMID: 39519172 PMC: 11547107. DOI: 10.3390/ijms252111620.


References
1.
Kaufmanova J, Stikarova J, Hlavackova A, Chrastinova L, Maly M, Suttnar J . Fibrin Clot Formation under Oxidative Stress Conditions. Antioxidants (Basel). 2021; 10(6). PMC: 8228070. DOI: 10.3390/antiox10060923. View

2.
Helms C, Kapadia S, Gilmore A, Lu Z, Basu S, Kim-Shapiro D . Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties. Blood Coagul Fibrinolysis. 2016; 28(5):356-364. PMC: 5419873. DOI: 10.1097/MBC.0000000000000602. View

3.
Zelzer S, Mangge H, Oberreither R, Bernecker C, Gruber H, Pruller F . Oxidative stress: Determination of 4-hydroxy-2-nonenal by gas chromatography/mass spectrometry in human and rat plasma. Free Radic Res. 2015; 49(10):1233-8. DOI: 10.3109/10715762.2015.1059936. View

4.
Prabhakaran S, Ruff I, Bernstein R . Acute stroke intervention: a systematic review. JAMA. 2015; 313(14):1451-62. DOI: 10.1001/jama.2015.3058. View

5.
Jin R, Mahoney C, Coleman Anderson L, Ottaviano F, Croce K, Leopold J . Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo. Circulation. 2011; 123(18):1963-73. PMC: 3107543. DOI: 10.1161/CIRCULATIONAHA.110.000034. View